Summary: Daily morning exposure to blue-wavelength light improved sleep, reduced PTSD symptom severity, and helped preserve the benefits of fear-extinction learning.
Source: University of Arizona
Researchers in the University of Arizona College of Medicine – Tucson’s Department of Psychiatry report that morning blue light therapy led to measurable improvements in sleep, decreased severity of post-traumatic stress disorder (PTSD) symptoms, and better retention of extinction memories compared with an amber light control. The study appears in Frontiers in Behavioral Neuroscience.
Sleep plays a central role in emotional regulation, learning and long-term recovery. Chronic sleep disruption can worsen physical and mental health, impair relationships and cognitive function, and undermine therapeutic progress. In people with PTSD, poor sleep is both a core symptom and a factor that can reduce the effectiveness of evidence-based treatments. High-quality sleep after therapy is important for integrating therapeutic gains and diminishing the power of traumatic memories.
“This research is exciting and unique because it points to an easy-to-use method for helping those with PTSD to retain the benefits of therapy long after the treatment ends,” said psychiatry professor William “Scott” Killgore, PhD, director of the Social, Cognitive and Affective Neuroscience (SCAN) Lab and senior author of the paper, “Morning blue light treatment improves sleep complaints, symptom severity, and retention of fear extinction memory in post-traumatic stress disorder.”
The SCAN Lab evaluated the effects of daily morning blue-wavelength light exposure on adults with clinically significant PTSD symptoms. Investigators aimed to determine whether a simple, drug-free intervention—30 minutes of morning blue light each day for six weeks—could improve sleep, reduce PTSD symptoms, and enhance consolidation and retention of fear extinction memories, which model the mechanisms underlying exposure-based therapies.
Eighty-one participants completed the intervention phase. Participants were randomly assigned to either blue-wavelength light therapy (BLT) or an amber light placebo (ALT) and instructed to use the device for 30 minutes each morning for six weeks. The study collected behavioral, autonomic and neurobiological measures before and after the intervention, including a validated fear conditioning and extinction protocol, skin conductance responses, and functional MRI during exposure to conditioned stimuli in a novel context.
Results showed that the 43 participants receiving morning blue light reported significant reductions in PTSD symptoms and sleep-related complaints. They also demonstrated better retention of extinction memories at follow-up, reflected in lower autonomic reactivity to previously extinguished stimuli and more stable neural responses. By contrast, the 39 participants in the amber light group did not retain extinction memory as well and showed a return of extinguished fear responses; this group also displayed greater reactivity in the left insula when viewing previously extinguished stimuli in a new context.
“While the limitations of the research include its modest sample size and challenges in measuring full compliance,” Dr. Killgore noted, “the advantages of a simple, nonpharmacological, low-cost intervention offer meaningful hope for many people living with the profound effects of PTSD.”
Jordan Karp, MD, professor and chair of the College of Medicine – Tucson’s Department of Psychiatry, added: “The data are thrilling. This nonpharmacological intervention is a promising life-changing and life-saving possibility for people suffering from PTSD.”
Funding: This study was supported by the US Army Medical Research and Development Command (W81XWH-14-0570).
About this PTSD and sleep research news
Author: David Bruzzese
Source: University of Arizona
Contact: David Bruzzese – University of Arizona
Image: The image is in the public domain
Original Research: Open access.
“Morning blue light treatment improves sleep complaints, symptom severity, and retention of fear extinction memory in post-traumatic stress disorder” by William “Scott” Killgore et al. Frontiers in Behavioral Neuroscience
Abstract
Morning blue light treatment improves sleep complaints, symptom severity, and retention of fear extinction memory in post-traumatic stress disorder
Disrupted sleep is a hallmark of many psychiatric conditions and undermines affective memory processing. In PTSD, sleep disturbances are common and appear to interfere with the consolidation and recall of extinction memories—memories formed during exposure-based therapies that help reduce conditioned fear.
The authors tested whether regulating circadian timing and improving sleep via morning blue-wavelength light therapy (BLT) would reduce PTSD symptoms, decrease sleep complaints, and enhance consolidation and retention of extinction memories compared with an amber light placebo (ALT).
Eighty-two individuals with PTSD completed a validated fear conditioning and extinction protocol and were then assigned to daily morning BLT or ALT for 30 minutes over six weeks. After the intervention, participants returned for extinction recall testing, which measured the difference in skin conductance response to extinguished versus never-extinguished stimuli and included fMRI assessment while viewing conditioned cues in a novel context.
Participants receiving BLT experienced correlated decreases in PTSD symptoms and sleep complaints, and maintained extinction memory at follow-up. Those in the ALT group showed impaired retention, with a restoration of previously extinguished fear responses and greater left insula reactivity when exposed to extinguished cues in a new context.
Daily morning exposure to blue-wavelength light was associated with stronger retention of extinction learning in patients with PTSD, as supported by autonomic and neurobiological measures. The authors propose that improved sleep and stabilized circadian rhythms after fear learning promoted consolidation of extinction memories, thereby reducing PTSD symptom expression and sleep-related complaints.
Because many frontline PTSD treatments rely on extinction principles, these findings suggest that adjunctive blue light therapy could strengthen therapeutic gains by supporting sleep-dependent consolidation of extinction memories.